Emergency Department Processes for the Evaluation and Management of Persons Under Investigation for Ebola Virus Disease
Item
Click for External Resource*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Item Type
PublicationTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Title
Emergency Department Processes for the Evaluation and Management of Persons Under Investigation for Ebola Virus Disease
Subject
Description
Due to the recent Ebola virus outbreak in West Africa, patients with epidemiologic risk for Ebola virus disease and symptoms consistent with Ebola virus disease are presenting to emergency departments (EDs) and clinics in the United States.
Date
2015-09-01
Type
Citation
Wadman, M. C., S. S. Schwedhelm, S. Watson, J. Swanhorst, S. G. Gibbs, J. J. Lowe, P. C. Iwen, A. K. Hayes, S. Needham, D. W. Johnson, D. J. Kalin, W. G. Zeger and R. L. Muelleman (2015). "Emergency Department Processes for the Evaluation and Management of Persons Under Investigation for Ebola Virus Disease." Ann Emerg Med 66(3): 306-314.
Abstract
INTRODUCTION: Due to the recent Ebola virus outbreak in West Africa, patients with epidemiologic risk for Ebola virus disease and symptoms consistent with Ebola virus disease are presenting to emergency departments (EDs) and clinics in the United States. These individuals, identified as a person under investigation for Ebola virus disease, are initially screened using a molecular assay for Ebola virus. If this initial test is negative and the person under investigation has been symptomatic for < 3 days, a repeat test is required after 3 days of symptoms to verify the negative result. In the time interval before the second test result is available, manifestations of the underlying disease process for the person under investigation, whether due to Ebola virus disease or some other etiology, may require further investigation to direct appropriate therapy. MATERIALS AND METHODS: ED administrators, physicians, and nurses proposed processes to provide care that is consistent with other ED patients. Biocontainment unit administrators, industrial hygienists, laboratory directors, physicians, and other medical personnel examined the ED processes and offered biocontainment unit personal protective equipment and process strategies designed to ensure safety for providers and patients. CONCLUSION: ED processes for the safe and timely evaluation and management of the person under investigation for Ebola virus disease are presented with the ultimate goals of protecting providers and ensuring a consistent level of care while confirmatory testing is pending.
Accessibility
pay online - or through clinicalkey, or elsevier subscription
Was this resource helpful?